![Ely Benaim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Ely Benaim è Chief Medical Officer di NovoCure Ltd. In passato il Dr. Benaim ha occupato la posizione di Vice Presidente-Affari clinici presso Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs presso Berg Pharma LLC, Senior Director-Clinical Research presso Millennium Pharmaceuticals, Inc., Chief Medical Officer di Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology presso Salmedix, Inc. e Assistant Professor presso la University of Tennessee. Il Dr. Benaim ha ricevuto un dottorato dall'Università Centrale del Venezuela.
Precedenti posizioni note di Ely Benaim
| Società | Posizione | Fine |
|---|---|---|
| NOVOCURE LIMITED | Direttore Tecnico/Scientifico/R&S | 17/01/2023 |
| REXAHN PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 31/03/2019 |
Berg Pharma LLC | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Direttore Tecnico/Scientifico/R&S | 01/01/2013 |
| SANGAMO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2010 |
Formazione di Ely Benaim
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
27
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Central University of Venezuela
 Central University of Venezuela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Berg Pharma LLC |
